ReviewAnnals of translational medicine2017
What are the ethical aspects surrounding the collegial decisional process in limiting and withdrawing treatment in intensive care?
Review in Annals of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Impact of Legal Protection on Life-Support Interventions and 3-Month Mortality in the Intensive Care Unit: The Vulne-Rea Study.Healthcare (Basel, Switzerland) · 2026Article
- Knowledge and attitudes of physicians in Chile toward Do-Not-Attempt-Resuscitation orders: A cross-sectional nation-wide study.SAGE open medicine · 2024Article
- Conscientious Objection and Other Motivations for Refusal to Treat in Hastened Death: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- ICU stays that are judged to be non-beneficial: A qualitative study of the perception of nursing staff.PloS one · 2023Article
- Non-beneficial admission to the intensive care unit: A nationwide survey of practices.PloS one · 2023Article
- Team-family conflicts over end-of-life decisions in ICU: A survey of French physicians' beliefs.PloS one · 2023Article
- Decision-making process during limitation life-sustaining support meetings in French intensive care units.Intensive care medicine · 2022Article
- Criteria deemed important by ICU patients when designating a reference person.Journal of intensive medicine · 2022Article
- Article
- Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery.Clinical case reports · 2021Article
- Non-readmission decisions in the intensive care unit: A qualitative study of physicians' experience in a multicentre French study.PloS one · 2021Article
- Non-readmission decisions in the intensive care unit under French rules: A nationwide survey of practices.PloS one · 2018Article
- What are the ethical dimensions in the profession of intensive care specialist?Annals of translational medicine · 2017Review
- Ethical aspects of admission or non-admission to the intensive care unit.Annals of translational medicine · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The decision to limit or withdraw life-support treatment is an integral part of the job of a physician working in the intensive care unit, and of the approach to care. However, this decision is influenced by a number of factors. It is widely accepted that a medical decision that will ultimate lead to end-of-life in the intensive care unit (ICU) must be shared between all those involved in the care process, and should give precedence to the patient's wishes (either directly expressed by the patient or in written form, such as advance directives), and taking into account the opinion of the patient's family, including the surrogate if the patient is no longer capable of expressing themselves. A number of questions still remain unanswered regarding how decisions to limit or withdraw treatment are taken in daily practice, especially when this decision can be anticipated. We discuss here the collegial procedure for decision-making, in particular in the context of recent French legislation on end-of-life issues. We describe how collegial decision-making procedures should be carried out, and what points are covered in shared discussions regarding decisions to limit or withdraw life-sustaining therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.